Hydroxyzine pamoate, 25 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen

Q0177
HCPCS Code

2023 HCPCS
Billable/Valid Code

Q0177 is a valid 2023 HCPCS Code that could be used to indicate Hydroxyzine pamoate, 25 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen for reimbursement purposes.

Q0177 belongs to Medical Care Type of Service and has been in effect since Apr 01, 1998.

Short description for Q0177 HCPCS code:

Hydroxyzine pamoate 25mg

HCPCS Q0177

Q0177 code information

HCPCS code:	Q0177
Description:	HYDROXYZINE PAMOATE, 25 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
Effective Date:	Apr 01, 1998
Added Date:	Apr 01, 1998
Termination Date:	HCPCS Q0177 was terminated on Nov 30, -0001
Pricing indicator:	`51` - DRUGS
Multi Pricing indicator:	`A` - NOT APPLICABLE AS HCPCS PRICED UNDER ONE METHODOLOGY
Coverage code:	`D` - SPECIAL COVERAGE INSTRUCTIONS APPLY
BETOS code:	`O1D` - CHEMOTHERAPY
Action code:	`N` - NO MAINTENANCE FOR THIS CODE
Type of Service:	`1` - MEDICAL CARE
Anesthesia BUQ:	0